PLM60 for Peripheral T Cell Lymphoma (PTCL)

首次发布于 2018 年 6 月 12 日

Minimal Residual Disease in Peripheral T-cell Lymphoma

计划入组 44 人 · 首次发布于 2017 年 9 月 29 日

Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma

计划入组 12 人 · 首次发布于 2016 年 10 月 26 日

Pralatrexate(Folotyn)

C₂₃H₂₃N₇O₅ · Rx

Belinostat(Beleodaq)

C₁₅H₁₄N₂O₄S

allogeneic CAR T-cell therapy

Bard Peripheral Vascular, Inc.

United States

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

T-Knife GmbH

Germany

Valemetostat Shows Promise in Relapsed/Refractory Peripheral T-Cell Lymphoma

CAR T-Cell Therapy AUTO4 Shows Promise in Treating Peripheral T-Cell Lymphoma

Secura Bio Reports Sustained Efficacy of Duvelisib in Heavily Pretreated Peripheral T-Cell Lymphoma Patients